{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T04:36:51Z","timestamp":1771303011480,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s10067-023-06761-y","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T13:02:32Z","timestamp":1694091752000},"page":"553-560","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chronic non-bacterial osteomyelitis and immune checkpoint molecules"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0426-9432","authenticated-orcid":false,"given":"Ummusen","family":"Kaya Akca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdal","family":"Sag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Busra","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur Kubra","family":"Tasdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muserref","family":"Kasap Cuceoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozge","family":"Basaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezgi Deniz","family":"Batu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yelda","family":"Bilginer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seza","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"issue":"3","key":"6761_CR1","first-page":"329","volume":"15","author":"A Giedion","year":"1972","unstructured":"Giedion A, Holthusen W, Masel L, Vischer D (1972) Subacute and chronic \u201csymmetrical\u201d osteomyelitis. Ann Radiol 15(3):329\u2013342","journal-title":"Ann Radiol"},{"issue":"1","key":"6761_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/rheumatology\/kel190","volume":"46","author":"A Jansson","year":"2007","unstructured":"Jansson A, Renner E, Ramser J et al (2007) Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology 46(1):154\u2013160","journal-title":"Rheumatology"},{"issue":"1","key":"6761_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.clim.2012.07.012","volume":"145","author":"SR Hofmann","year":"2012","unstructured":"Hofmann SR, Morbach H, Schwarz T, R\u00f6sen-Wolff A, Girschick HJ, Hedrich CM (2012) Attenuated TLR4\/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression. Clin Immunol 145(1):69\u201376","journal-title":"Clin Immunol"},{"issue":"3","key":"6761_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.clim.2011.08.012","volume":"141","author":"S Hofmann","year":"2011","unstructured":"Hofmann S, Schwarz T, M\u00f6ller J et al (2011) Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. Clin Immunol 141(3):317\u2013327","journal-title":"Clin Immunol"},{"issue":"6","key":"6761_CR5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s11914-017-0405-9","volume":"15","author":"SR Hofmann","year":"2017","unstructured":"Hofmann SR, Kapplusch F, Girschick HJ et al (2017) Chronic recurrent multifocal osteomyelitis (CRMO): presentation, pathogenesis, and treatment. Curr Osteoporos Rep 15(6):542\u2013554","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"6761_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.clim.2015.09.013","volume":"161","author":"S Hofmann","year":"2015","unstructured":"Hofmann S, Kubasch A, Ioannidis C et al (2015) Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1\u03b2 expression and release. Clinical immunology 161(2):300\u2013307","journal-title":"Clinical immunology"},{"issue":"11","key":"6761_CR7","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3899\/jrheum.160256","volume":"43","author":"SR Hofmann","year":"2016","unstructured":"Hofmann SR, Schnabel A, R\u00f6sen-Wolff A, Morbach H, Girschick HJ, Hedrich CM (2016) Chronic nonbacterial osteomyelitis: pathophysiological concepts and current treatment strategies. J Rheumatol 43(11):1956\u20131964","journal-title":"J Rheumatol"},{"key":"6761_CR8","doi-asserted-by":"publisher","first-page":"645699","DOI":"10.3389\/fimmu.2021.645699","volume":"12","author":"Y Zhai","year":"2021","unstructured":"Zhai Y, Moosavi R, Chen M (2021) Immune checkpoints, a novel class of therapeutic targets for autoimmune diseases. Front Immunol 12:645699","journal-title":"Front Immunol"},{"issue":"6","key":"6761_CR9","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/art.27417","volume":"62","author":"H Kristjansdottir","year":"2010","unstructured":"Kristjansdottir H, Steinsson K, Gunnarsson I, Gr\u00f6ndal G, Erlendsson K, Alarc\u00f3n-Riquelme ME (2010) Lower expression levels of the programmed death 1 receptor on CD4+ CD25+ T cells and correlation with the PD-1.3 A genotype in patients with systemic lupus erythematosus. Arthritis Rheum 62(6):1702\u20131711","journal-title":"Arthritis Rheum"},{"issue":"7","key":"6761_CR10","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1002\/art.27500","volume":"62","author":"AP Raptopoulou","year":"2010","unstructured":"Raptopoulou AP, Bertsias G, Makrygiannakis D et al (2010) The programmed death 1\/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis. Arthritis Rheum 62(7):1870\u20131880","journal-title":"Arthritis Rheum"},{"issue":"8","key":"6761_CR11","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/1346-8138.13339","volume":"43","author":"K Yanaba","year":"2016","unstructured":"Yanaba K, Hayashi M, Yoshihara Y, Nakagawa H (2016) Serum levels of soluble programmed death-1 and programmed death ligand-1 in systemic sclerosis: association with extent of skin sclerosis. J Dermatol 43(8):954\u2013957","journal-title":"J Dermatol"},{"issue":"1","key":"6761_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jfma.2020.04.004","volume":"120","author":"S Zhang","year":"2021","unstructured":"Zhang S, Wang L, Li M, Zhang F, Zeng X (2021) The PD-1\/PD-L pathway in rheumatic diseases. J Formos Med Assoc 120(1):48\u201359","journal-title":"J Formos Med Assoc"},{"issue":"6","key":"6761_CR13","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/MAJ.0000000000000468","volume":"349","author":"L Zhou","year":"2015","unstructured":"Zhou L, Xu H, Hu L et al (2015) Decreased programmed death-1 expression on the T cells of patients with ankylosing spondylitis. Am J Med Sci 349(6):488\u2013492","journal-title":"Am J Med Sci"},{"issue":"1","key":"6761_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5582\/bst.2016.01171","volume":"11","author":"Z Duan","year":"2017","unstructured":"Duan Z, Gui Y, Li C et al (2017) The immune dysfunction in ankylosing spondylitis patients. Biosci Trends 11(1):69\u201376","journal-title":"Biosci Trends"},{"issue":"6","key":"6761_CR15","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1365-2133.2011.10274.x","volume":"164","author":"J Sim","year":"2011","unstructured":"Sim J, Park M, Park S, Lee ES (2011) Altered expression of costimulatory molecules in Beh\u00e7et\u2019s disease according to clinical activity. Br J Dermatol 164(6):1285\u20131291","journal-title":"Br J Dermatol"},{"issue":"3","key":"6761_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/0022034520901519","volume":"99","author":"H Yahara","year":"2020","unstructured":"Yahara H, Horita S, Yanamoto S et al (2020) A targeted genetic association study of the rare type of osteomyelitis. J Dent Res 99(3):271\u2013276","journal-title":"J Dent Res"},{"key":"6761_CR17","doi-asserted-by":"publisher","first-page":"959575","DOI":"10.3389\/fimmu.2022.959575","volume":"13","author":"CM Sergi","year":"2022","unstructured":"Sergi CM, Miller E, Demellawy DE, Shen F, Zhang M (2022) Chronic recurrent multifocal osteomyelitis. A narrative and pictorial review. Front Immunol 13:959575","journal-title":"Front Immunol"},{"key":"6761_CR18","doi-asserted-by":"publisher","first-page":"101384","DOI":"10.1016\/j.tranon.2022.101384","volume":"19","author":"NZ Malinga","year":"2022","unstructured":"Malinga NZ, Siwele SC, Steel HC et al (2022) Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1\/PD-L1 and TIM-3 are markedly increased in basal cell carcinoma. Transl Oncol 19:101384","journal-title":"Transl Oncol"},{"issue":"2","key":"6761_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/eji.201948382","volume":"50","author":"YH Zhang","year":"2020","unstructured":"Zhang YH, Sun HX (2020) Immune checkpoint molecules in pregnancy: focus on regulatory T cells. Eur J Immunol 50(2):160\u2013169","journal-title":"Eur J Immunol"},{"issue":"8","key":"6761_CR20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/rheumatology\/keh663","volume":"44","author":"C Wong","year":"2005","unstructured":"Wong C, Lit L, Tam L, Li E, Lam C (2005) Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology 44(8):989\u2013994","journal-title":"Rheumatology"},{"issue":"4","key":"6761_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.intimp.2012.08.004","volume":"14","author":"J Cao","year":"2012","unstructured":"Cao J, Zou L, Chen P, Zhang L (2012) Increased production of circulating soluble co-stimulatory molecules CTLA-4, CD28 and CD80 in patients with rheumatoid arthritis. Int Immunopharmacol 14(4):585\u2013592","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"6761_CR22","doi-asserted-by":"publisher","first-page":"8844","DOI":"10.4049\/jimmunol.177.12.8844","volume":"177","author":"B Wan","year":"2006","unstructured":"Wan B, Nie H, Liu A et al (2006) Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J Immunol 177(12):8844\u20138850","journal-title":"J Immunol"},{"issue":"1","key":"6761_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s10753-013-9718-8","volume":"37","author":"S Li","year":"2014","unstructured":"Li S, Liao W, Chen M et al (2014) Expression of programmed death-1 (PD-1) on CD4+ and CD8+ T cells in rheumatoid arthritis. Inflammation 37(1):116\u2013121","journal-title":"Inflammation"},{"issue":"4","key":"6761_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nm.2106","volume":"16","author":"EA Said","year":"2010","unstructured":"Said EA, Dupuy FP, Trautmann L et al (2010) Programmed death-1\u2013induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med 16(4):452\u2013459","journal-title":"Nat Med"},{"issue":"2","key":"6761_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2217\/imt-2017-0120","volume":"10","author":"N Kuol","year":"2018","unstructured":"Kuol N, Stojanovska L, Nurgali K, Apostolopoulos V (2018) PD-1\/PD-L1 in disease. Immunotherapy 10(2):149\u2013160","journal-title":"Immunotherapy"},{"key":"6761_CR26","doi-asserted-by":"publisher","first-page":"1161067","DOI":"10.3389\/fimmu.2023.1161067","volume":"14","author":"V Carlini","year":"2023","unstructured":"Carlini V, Noonan DM, Abdalalem E et al (2023) The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Front Immunol 14:1161067","journal-title":"Front Immunol"},{"issue":"2","key":"6761_CR27","doi-asserted-by":"publisher","first-page":"650","DOI":"10.22207\/JPAM.15.2.08","volume":"15","author":"DM Ibrahim","year":"2021","unstructured":"Ibrahim DM, Mahmoud FM, Zaki WK, Hamza AH, ElSheshtawy NM (2021) Expression of programmed cell death 1 (PD-1) as a marker of T-cell exhaustion and its correlation with interleukin-10 serum level in patients with COVID-19. J Pure Appl Microbiol 15(2):650\u2013657","journal-title":"J Pure Appl Microbiol"},{"issue":"8","key":"6761_CR28","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M (2015) Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 15(8):486\u2013499","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"6761_CR29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.clim.2010.07.012","volume":"137","author":"Y Liu","year":"2010","unstructured":"Liu Y, Shu Q, Gao L et al (2010) Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity. Clin Immunol 137(2):288\u2013295","journal-title":"Clin Immunol"},{"issue":"8","key":"6761_CR30","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s10067-018-4076-4","volume":"37","author":"Z Koohini","year":"2018","unstructured":"Koohini Z, Hossein-Nataj H, Mobini M, Hosseinian-Amiri A, Rafiei A, Asgarian-Omran H (2018) Analysis of PD-1 and Tim-3 expression on CD4+ T cells of patients with rheumatoid arthritis; negative association with DAS28. Clin Rheumatol 37(8):2063\u20132071","journal-title":"Clin Rheumatol"},{"key":"6761_CR31","first-page":"1","volume":"350","author":"C Zhu","year":"2011","unstructured":"Zhu C, Anderson AC, Kuchroo VK (2011) TIM-3 and its regulatory role in immune responses. Curr Top Microbiol Immunol 350:1\u201315","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"6761_CR32","first-page":"414","volume":"80","author":"X Huang","year":"2021","unstructured":"Huang X, Li T, Chen J, Huang Z, Chen S, Guo X (2021) POS0369 Elevated expression of TIM-3 on neutrophils correlates with disease activity and severity of ankylosing spondylitis. Ann Rheum Dis 80(1):414\u2013415","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06761-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06761-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06761-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T16:20:43Z","timestamp":1704730843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06761-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["6761"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06761-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,7]]},"assertion":[{"value":"22 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study has been approved by Hacettepe University Ethics Commission (Approval Number: GO 19\/158). All participating patients gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}